These benefits, along with a preceding report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,two aid the principle of targeting ACKR3 as a novel strategy to modulate the opioid system, which could open new therapeutic avenues for opioid-relevant Con